Bracing for Impact: Preparing for the 2019 Specialty Drug Spend - Nexus 2017

Title:  Bracing for Impact: Preparing for the 2019 Specialty Drug Spend

ACPE UAN #:  0233-9999-17-068-H04-P

Release Date:  October 18, 2017

Expiration Date:  October 18, 2020

Activity Type:    Knowledge-based

Contact Hours:  1.5

Activity Fee:  Member:  Free        Non-Member: $30 (This home study also sold as part of the "Best of AMCP Nexus 2017" one-time subscription set)

Target Audience: Pharmacists who practice in managed care settings.

The live session was presented jointly by AMCP and PRIME Education, LLC and accredited for pharmacists, physicians, and nurses. However, this home study is only accredited for pharmacists.

Activity overview

The escalating cost of prescription drugs is an issue that continues to plague the U.S. health care system, accounting for 17% of the total health care spending in 2015. Furthermore, the increase in spending on prescription drugs has outpaced projections, increasing by 20% between 2013 and 2015, compared to the 11% predicted growth. Now more than ever, payers need to anticipate high-cost, high-impact agents and proactively design innovative management strategies before new drugs reach the market.  This session will focus on traditional and specialty drugs that are expected to receive FDA approval within the next 2 years.  Participants will leave armed with in-depth information about efficacy and safety, predicted place in therapy, and probable budgetary impact of each of these drugs—and ready to face the specter of spiraling drug costs.

Learning Objectives:  

At the completion of this activity, participants should be able to:

1. Recognize high-impact traditional and specialty drugs in the 2018–2019 pharmaceutical pipeline.

2. Summarize efficacy and safety data for high-impact pipeline drugs.

3. Explain how emerging pipeline drugs compare with currently available therapeutic options.

4. Explain the role in the therapy of pipeline drugs for specific specialty disorders and discuss their budgetary impact on managed care pharmacy teams. 

Schedule of Educational Activity

This activity consists of an audio recording, pre-test assessment questions (not required to pass or continue), post-test questions (required to pass with a score of 70% or higher) and a specific activity evaluation. 


The Academy of Managed Care Pharmacy (AMCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

As an accredited provider, AMCP strictly adheres to the ACPE Standards for Commercial Support and other relevant guidelines and standards to ensure the independence of continuing pharmacy education (CPE) activities.  It is AMCP’s intent that all CPE activities be independent, objective, balanced, evidence-based and free of any commercial bias.

CPE Requirements:   

Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live activity presented at AMCP Nexus 2017. 

CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor.  Please allow 72 hours for processing and posting in your NABP account.

To receive credit for an online activity you must:

  •  Review the full content of the activity.
  •  Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
  •  Complete a specific activity evaluation.

System Technical Requirements/Viewing Requirements: System Requirements Courses and learning activities are delivered via your Web browser and Acrobat PDF. For all activities, you should have a basic comfort level using a computer and navigating web sites.  View the minimum technical and system requirements for continuing education online learning activities. 


Jeremy Schafer, PharmD, MBA | Senior Vice President, Director Payer Access Solutions | Precision for Value | New York, New York

Credit Information

Activity Number Credit Amount Accreditation Period
ACPE UAN #0233-9999-17-068-H04-P 1.5 Contact Hours October 18, 2017 - October 18, 2020